Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  NAQUI ALI
 2. Date of Event Requiring Statement (Month/Day/Year)
01/23/2006		 3. Issuer Name and Ticker or Trading Symbol
IDEXX LABORATORIES INC /DE [IDXX]
(Last)
(First)
(Middle)
C/O IDEXX IDEXX LABORATORIES, INC., ONE IDEXX DRIVE		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Vice President
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

WESTBROOK, ME 04092		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 280
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Incentive Stock Option (right to buy)   (1) 02/07/2011 Common Stock 2,000 $ 22.6875 D  
Incentive Stock Option (right to buy)   (2) 02/03/2009 Common Stock 752 $ 24.5 D  
Incentive Stock Option (right to buy)   (3) 02/12/2012 Common Stock 5,905 $ 26.63 D  
Incentive Stock Option (right to buy)   (4) 02/06/2013 Common Stock 2,797 $ 34.27 D  
Incentive Stock Option (right to buy)   (5) 02/04/2014 Common Stock 1,885 $ 50.9 D  
Incentive Stock Option (right to buy)   (6) 02/02/2015 Common Stock 1,839 $ 57.31 D  
Non-Qualified Stock Option (right to buy)   (7) 02/12/2012 Common Stock 7,095 $ 26.63 D  
Non-Qualified Stock Option (right to buy)   (4) 02/06/2013 Common Stock 6,703 $ 34.27 D  
Non-Qualified Stock Option (right to buy)   (5) 02/04/2014 Common Stock 4,115 $ 50.9 D  
Non-Qualified Stock Option (right to buy)   (6) 02/02/2015 Common Stock 3,961 $ 57.31 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
NAQUI ALI
C/O IDEXX IDEXX LABORATORIES, INC.
ONE IDEXX DRIVE
WESTBROOK, ME 04092		       Vice President  

Signatures

Conan R. Deady, Attorney-in-Fact for Ali Naqui, PhD 01/27/2006
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Grant of option to buy shares of Common Stock exercisable as to 312 shares on 2/07/2004, and 2,000 shares on 2/07/2005 and 2/07/2006.
(2) Grant of option to buy shares of Common Stock exercisable in five equal annual increments, beginning on the first anniversary date (2/03/2000) of the date of grant.
(3) Grant of option to buy shares of Common Stock exercisable as to 1,254 shares on 2/12/2005, 2,051 shares on 2/12/2006 and 2,600 shares on 2/12/2007.
(4) Grant of option to buy shares of Common Stock exercisable in five equal annual increments, beginning on the first anniversary date (2/06/2004) of the date of grant.
(5) Grant of option to buy shares of Common Stock exercisable in five equal annual increments, beginning on the first anniversary date (2/05/2005) of the date of grant.
(6) Grant of option to buy shares of Common Stock exercisable in five equal annual increments, beginning on the first anniversary date (2/03/2006) of the date of grant.
(7) Grant of option to buy shares of Common Stock exercisable as to 2,600 shares on 2/12/2003 and 2/12/2004, 1,346 shares on 2/12/2005, and 549 shares on 2/12/2006.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.